306 related articles for article (PubMed ID: 21035759)
1. A liver-derived secretory protein, selenoprotein P, causes insulin resistance.
Misu H; Takamura T; Takayama H; Hayashi H; Matsuzawa-Nagata N; Kurita S; Ishikura K; Ando H; Takeshita Y; Ota T; Sakurai M; Yamashita T; Mizukoshi E; Yamashita T; Honda M; Miyamoto K; Kubota T; Kubota N; Kadowaki T; Kim HJ; Lee IK; Minokoshi Y; Saito Y; Takahashi K; Yamada Y; Takakura N; Kaneko S
Cell Metab; 2010 Nov; 12(5):483-95. PubMed ID: 21035759
[TBL] [Abstract][Full Text] [Related]
2. [Novel strategies that target hepatokines for treatment of type 2 diabetes].
Misu H; Takamura T; Kaneko S
Nihon Rinsho; 2012 Jan; 70(1):157-63. PubMed ID: 22413512
[TBL] [Abstract][Full Text] [Related]
3. Protectin DX ameliorates palmitate-induced hepatic insulin resistance through AMPK/SIRT1-mediated modulation of fetuin-A and SeP expression.
Jung TW; Ahn SH; Shin JW; Kim HC; Park ES; Abd El-Aty AM; Hacımüftüoğlu A; Song KH; Jeong JH
Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):898-909. PubMed ID: 31246318
[TBL] [Abstract][Full Text] [Related]
4. Increased hepatic lipogenesis in insulin resistance and Type 2 diabetes is associated with AMPK signalling pathway up-regulation in Psammomys obesus.
Ben Djoudi Ouadda A; Levy E; Ziv E; Lalonde G; Sané AT; Delvin E; Elchebly M
Biosci Rep; 2009 Jun; 29(5):283-92. PubMed ID: 18842111
[TBL] [Abstract][Full Text] [Related]
5. Unmetabolized fenofibrate, but not fenofibric acid, activates AMPK and inhibits the expression of phosphoenolpyruvate carboxykinase in hepatocytes.
Murakami R; Murakami H; Kataoka H; Cheng XW; Takahashi R; Numaguchi Y; Murohara T; Okumura K
Life Sci; 2010 Oct; 87(15-16):495-500. PubMed ID: 20849861
[TBL] [Abstract][Full Text] [Related]
6. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.
Koo SH; Satoh H; Herzig S; Lee CH; Hedrick S; Kulkarni R; Evans RM; Olefsky J; Montminy M
Nat Med; 2004 May; 10(5):530-4. PubMed ID: 15107844
[TBL] [Abstract][Full Text] [Related]
7. AMPK activator-mediated inhibition of endoplasmic reticulum stress ameliorates carrageenan-induced insulin resistance through the suppression of selenoprotein P in HepG2 hepatocytes.
Jung TW; Lee SY; Hong HC; Choi HY; Yoo HJ; Baik SH; Choi KM
Mol Cell Endocrinol; 2014 Jan; 382(1):66-73. PubMed ID: 24055274
[TBL] [Abstract][Full Text] [Related]
8. mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat.
Chotechuang N; Azzout-Marniche D; Bos C; Chaumontet C; Gausserès N; Steiler T; Gaudichon C; Tomé D
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1313-23. PubMed ID: 19738034
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of hepatic expression and secretion of selenoprotein P by metformin.
Speckmann B; Sies H; Steinbrenner H
Biochem Biophys Res Commun; 2009 Sep; 387(1):158-63. PubMed ID: 19576170
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase.
Hegarty BD; Turner N; Cooney GJ; Kraegen EW
Acta Physiol (Oxf); 2009 May; 196(1):129-45. PubMed ID: 19245658
[TBL] [Abstract][Full Text] [Related]
11. Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling.
Cho CY; Koo SH; Wang Y; Callaway S; Hedrick S; Mak PA; Orth AP; Peters EC; Saez E; Montminy M; Schultz PG; Chanda SK
Cell Metab; 2006 May; 3(5):367-78. PubMed ID: 16679294
[TBL] [Abstract][Full Text] [Related]
12. Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells.
Ishikura K; Misu H; Kumazaki M; Takayama H; Matsuzawa-Nagata N; Tajima N; Chikamoto K; Lan F; Ando H; Ota T; Sakurai M; Takeshita Y; Kato K; Fujimura A; Miyamoto K; Saito Y; Kameo S; Okamoto Y; Takuwa Y; Takahashi K; Kidoya H; Takakura N; Kaneko S; Takamura T
Diabetologia; 2014 Sep; 57(9):1968-76. PubMed ID: 24989996
[TBL] [Abstract][Full Text] [Related]
13. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
14. Identification of hepatokines involved in pathology of type 2 diabetes and obesity.
Misu H
Endocr J; 2019 Aug; 66(8):659-662. PubMed ID: 31366824
[TBL] [Abstract][Full Text] [Related]
15. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
16. Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes.
Takayama H; Misu H; Iwama H; Chikamoto K; Saito Y; Murao K; Teraguchi A; Lan F; Kikuchi A; Saito R; Tajima N; Shirasaki T; Matsugo S; Miyamoto K; Kaneko S; Takamura T
J Biol Chem; 2014 Jan; 289(1):335-45. PubMed ID: 24257750
[TBL] [Abstract][Full Text] [Related]
17. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis.
Yang SJ; Hwang SY; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1325-9. PubMed ID: 21677040
[TBL] [Abstract][Full Text] [Related]
18. LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance.
Lan F; Misu H; Chikamoto K; Takayama H; Kikuchi A; Mohri K; Takata N; Hayashi H; Matsuzawa-Nagata N; Takeshita Y; Noda H; Matsumoto Y; Ota T; Nagano T; Nakagen M; Miyamoto K; Takatsuki K; Seo T; Iwayama K; Tokuyama K; Matsugo S; Tang H; Saito Y; Yamagoe S; Kaneko S; Takamura T
Diabetes; 2014 May; 63(5):1649-64. PubMed ID: 24478397
[TBL] [Abstract][Full Text] [Related]
19. Endogenous Selenoprotein P, a Liver-Derived Secretory Protein, Mediates Myocardial Ischemia/Reperfusion Injury in Mice.
Chadani H; Usui S; Inoue O; Kusayama T; Takashima SI; Kato T; Murai H; Furusho H; Nomura A; Misu H; Takamura T; Kaneko S; Takamura M
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29547524
[TBL] [Abstract][Full Text] [Related]
20. Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models.
Mita Y; Nakayama K; Inari S; Nishito Y; Yoshioka Y; Sakai N; Sotani K; Nagamura T; Kuzuhara Y; Inagaki K; Iwasaki M; Misu H; Ikegawa M; Takamura T; Noguchi N; Saito Y
Nat Commun; 2017 Nov; 8(1):1658. PubMed ID: 29162828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
